NK cell applications phase I/II study: NK-DLI post haplo-SCT.

BW: kg/body weight, cryo (c): cryopreserved, fresh (f): freshly applied, f: female, GvL/T: graft-versus-leukemia/tumor, haplo-SCT: haploidentical stem cell transplantation, HvG: host-versus-graft, KIR: killer cell immunoglobulin-like receptor, m: male, MM: mismatch, No.: number, n.s.: not specified, NK-DLI: NK cell donor lymphocyte infusion, SCT: stem cell transplantation, *patients received both NK-DLIunstim and NK-DLIIL-2 stim, #under detection limit, §difference statistically not significant, §§difference statistically significant.